Legal Representation
Attorney
Khanh T. Glatzel
USPTO Deadlines
Next Deadline
64 days remaining
Non-Final Action E-Mailed
Due Date
February 19, 2026
Extension Available
Until May 19, 2026
Application History
7 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 19, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 19, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 19, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 12, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 30, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 23, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jun 23, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment and prevention of chronic obstructive pulmonary disease, pulmonary arterial hypertension, acute liver failure, acute-on-chronic liver failure, liver fibrosis, metabolic dysfunction associated fatty liver disease, nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, lung fibrosis, organ fibrosis, and inflammatory diseases
Class 042
Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Testing of pharmaceuticals
First Use Anywhere:
Oct 30, 2023
First Use in Commerce:
Oct 30, 2023
Classification
International Classes
005
042